VANCOUVER, BC, April 9, 2024 /PRNewswire/ - Numinus Wellness
Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX:
NUMIF), a mental health care company advancing traditional and
innovative behavioural health treatments with a focus on safe,
evidence-based psychedelic-assisted therapies, will release its
financial results for the quarter ended February 29, 2024,
after market close on Monday, April 15, 2024.
Interested parties are invited to participate in the Company's
Q2 2024 results conference call and webcast, which will be held on
the same day at 5:30 p.m. Eastern time / 2:30 p.m.
Pacific time. During the call, Numinus executives will review the
Company's performance and recent initiatives.
A question-and-answer session will follow management's prepared
remarks. At this time, the operator will provide instructions for
qualified equity analysts to submit questions. Investors are
invited to submit questions by email to invest@numinus.com. A
selection of questions will be answered by management on the call,
and all emailed questions will be responded to by email.
To listen to the live webcast, please register at:
https://events.q4inc.com/attendee/472052579
The webcast will also be archived on the Events and
Presentations page of Numinus' Investor Relations website:
https://www.investors.numinus.com/events-and-presentations/
To participate in the live conference call, please use the
following dial-in information:
- 1 (888) 330-3632 (Toll-free North America)
- 1 (646) 960-0837 (International)
- Ask to participate in Numinus' Q2 2024 Results Call
To avoid any delays in joining the call, please dial in at least
five minutes before the call starts. If prompted, please provide
conference passcode 3547386.
About Numinus
Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF) helps people to
heal and be well through the development and delivery of innovative
mental health care and access to safe, evidence-based
psychedelic-assisted therapies. The Numinus model – including
psychedelic research and clinic care – is at the forefront of a
transformation aimed at healing rather than managing symptoms for
depression, anxiety, trauma, pain and substance use. At Numinus, we
are leading the integration of psychedelic-assisted therapies into
mainstream clinical practice and building the foundation for a
healthier society.
Learn more at www.numinus.com and follow us
on LinkedIn, Facebook, Twitter,
and Instagram.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/numinus-to-host-q2-fiscal-2024-results-conference-call-on-april-15-2024-302111089.html
SOURCE Numinus Wellness Inc.
